The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

Inclusion Criteria: * Clinically diagnosed onychomycosis of the target nail * Presence of mild to moderate onychomycosis, defined as 20 - 50% of the area of the target nail being clinically affected * Has a positive KOH examination from the target nail * Has a positive dermatophyte culture from the target nail Exclusion Criteria: * Presence of any disease or condition that might cause nail abnormalities or may interfere with the evaluation of the study drug * Use of any systemic antifungal therapy within 4 weeks prior to the Screening visit or non-responsive to systemic antifungal therapy for onychomycosis * Use of any prescription or over-the-counter topical antifungal therapy for the toenails within 4 weeks prior to the Screening visit * Woman who is pregnant, nursing an infant, or planning a pregnancy during the study period